Talking ATTD, 780G, Rumors And Missteps With Medtronic’s Diabetes Leaders

Medtech Insight spoke to the president of Medtronic’s diabetes business, Que Dallara, as well as two of the company’s medical affairs directors, about the company’s recently published data, and the timeline for the US launch of its 780G system.

Blood Glucose
• Source: Shutterstock

More from Clinical Trials

More from R&D